Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -42.61% is 32% below its 5-year average of -32.29%, around the middle of its 5-year range (-79.28%–-22.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.16% above its 12-month average of -42.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -42.61%.
RETURN ON INVESTED CAPITAL (ROIC)
-42.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-32.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-45.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.16%
CURRENT VS 3Y AVG
-33.04%
CURRENT VS 5Y AVG
-31.98%
CURRENT VS 10Y AVG
+6.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.19%
median of 716 covered companies
CURRENT VS SECTOR MEDIAN
-28.40%
vs the sector median at left
ProQR Therapeutics N.V.
Market Cap
$173.23M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-42.68%
3Y Avg
-32.03%
5Y Avg
-32.29%
Market Cap
$173.38M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$173.18M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$174.03M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$171.62M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$176.38M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$169.85M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$177.93M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$165.58M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.23M | -42.61% | -42.68% | -32.03% | -32.29% |
| Nkarta, Inc. (NKTX)vs › | $173.38M | -42.11% | -29.16% | -30.37% | -28.38% |
| Cue Biopharma, Inc. (CUE)vs › | $173.18M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.03M | -30.23% | -28.70% | -31.34% | -41.69% |
| MediWound Ltd. (MDWD)vs › | $171.62M | -58.55% | -41.33% | -32.67% | -48.97% |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.38M | -46.59% | -39.23% | -33.74% | -53.74% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | -8.34% | 4.10% | 3.63% | 7.54% |
| Journey Medical Corporation (DERM)vs › | $177.93M | -5.22% | -22.12% | -29.09% | -27.39% |
| OptimizeRx Corp. (OPRX)vs › | $165.58M | 4.92% | -1.65% | -7.20% | -5.46% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | -3.21% | -7.29% | -11.96% | -13.56% |
ROIC
-42.6%
ROE
-54.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -42.61% |
| 2026-03-31 | -59.57% |
| 2025-12-31 | -42.81% |
| 2025-09-30 | -37.72% |
| 2025-06-30 | -30.69% |
| 2025-03-31 | -24.98% |
| 2024-12-31 | -22.85% |
| 2024-09-30 | -32.86% |
| 2024-06-30 | -27.87% |
| 2024-03-31 | -30.23% |
| 2023-12-31 | -26.89% |
| 2023-09-30 | -30.68% |
| 2023-06-30 | -34.16% |
| 2023-03-31 | -34.87% |
| 2022-12-31 | -38.74% |
| 2022-09-30 | -79.28% |
| 2022-06-30 | -40.95% |
| 2022-03-31 | -33.14% |
| 2021-12-31 | -27.25% |
| 2021-09-30 | -27.73% |
| 2021-06-30 | -26.43% |
| 2021-03-31 | -39.06% |
| 2020-12-31 | -36.05% |
| 2020-09-30 | -38.83% |
| 2020-06-30 | -52.26% |
| 2020-03-31 | -57.08% |
| 2019-12-31 | -47.45% |
| 2019-09-30 | -70.28% |
| 2019-06-30 | -48.24% |
| 2019-03-31 | -40.09% |
| 2018-12-31 | -31.96% |
| 2018-09-30 | -27.37% |
| 2018-06-30 | -108.19% |
| 2018-03-31 | -85.28% |
| 2017-12-31 | -69.26% |
| 2017-09-30 | -95.85% |
| 2017-06-30 | -90.09% |
| 2017-03-31 | -80.56% |
| 2016-12-31 | -70.64% |
| 2016-09-30 | -54.76% |
| 2016-06-30 | -43.74% |
| 2016-03-31 | -33.38% |
| 2015-12-31 | -30.54% |
| 2015-09-30 | -24.56% |
| 2015-06-30 | -22.50% |
| 2015-03-31 | -21.42% |
| 2014-12-31 | -15.65% |
| 2014-09-30 | -12.14% |
| 2014-06-30 | -24.96% |
